|
|
||||||||
American Journal of Clinical Nutrition, Vol 29, 1300-1306, Copyright © 1976 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
SL Teitelbaum
Recent studies employing analogs of vitamin D in the treatment of clinical and experimental renal osteodystrophy indicate remarkable healing of morphological and biochemical skeletal lesions. After short periods of therapy, 25-hydroxycholecalciferol or 1,25- dihydroxycholecalciferol normalizes most of the histological abnormalities of the human uremic skeleton and significantly suppresses elevated levels of circulating immunoreactive parathyroid hormone. 25- Hydroxycholecalciferol appears to stimulate individual osteoblastic activity but does not increase the number of bone forming cells. Accumulated evidence suggests a direct effect of vitamin D and its metabolites on uremic bone.
This article has been cited by other articles:
![]() |
R. Recker, P. Schoenfeld, J. Letteri, E. Slatopolsky, R. Goldsmith, and A. Brickman The Efficacy of Calcifediol in Renal Osteodystrophy Arch Intern Med, May 15, 1978; 138(Suppl_5): 857 - 863. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |